In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]

The cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of man...

Full description

Bibliographic Details
Main Author: Luca Massimino
Format: Article
Language:English
Published: F1000 Research Ltd 2017-01-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/6-69/v1
id doaj-e869c3689ea24bf3879a5204e9ce1b37
record_format Article
spelling doaj-e869c3689ea24bf3879a5204e9ce1b372020-11-25T03:05:33ZengF1000 Research LtdF1000Research2046-14022017-01-01610.12688/f1000research.10631.111455In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]Luca Massimino0Molecular Oncology Unit, San Gerardo Hospital, Monza, ItalyThe cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of many different medical conditions. Nevertheless, even if a large amount of high-throughput functional genomic data exists, most researchers feature a strong background in molecular biology but lack advanced bioinformatics skills. In this work, publicly available gene expression datasets have been analyzed giving rise to a total of 40,224 gene expression profiles taken from cannabis plant tissue at different developmental stages. The resource presented here will provide researchers with a starting point for future investigations with Cannabis sativa.https://f1000research.com/articles/6-69/v1BioinformaticsGenomics
collection DOAJ
language English
format Article
sources DOAJ
author Luca Massimino
spellingShingle Luca Massimino
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
F1000Research
Bioinformatics
Genomics
author_facet Luca Massimino
author_sort Luca Massimino
title In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
title_short In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
title_full In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
title_fullStr In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
title_full_unstemmed In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
title_sort in silico gene expression profiling in cannabis sativa [version 1; referees: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2017-01-01
description The cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of many different medical conditions. Nevertheless, even if a large amount of high-throughput functional genomic data exists, most researchers feature a strong background in molecular biology but lack advanced bioinformatics skills. In this work, publicly available gene expression datasets have been analyzed giving rise to a total of 40,224 gene expression profiles taken from cannabis plant tissue at different developmental stages. The resource presented here will provide researchers with a starting point for future investigations with Cannabis sativa.
topic Bioinformatics
Genomics
url https://f1000research.com/articles/6-69/v1
work_keys_str_mv AT lucamassimino insilicogeneexpressionprofilingincannabissativaversion1referees2approved
_version_ 1724677850075758592